Argonaut Capital Management Corp. »

Biogen Idec shares owned by Argonaut Capital Management Corp.

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Argonaut Capital Management Corp. from 13F filings

Historical chart of Argonaut Capital Management Corp. investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Argonaut Capital Management Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Argonaut Capital Management Corp.

Quarter filed Position value Share count Share price at filing
2015-09-30 $292k 1.0k 292.00
2015-06-30 $404k 1.0k 404.00

More positions owned by Argonaut Capital Management Corp.

Delta Air Lines Inc Del Com New (DAL)
Gilead Sciences (GILD)
Apple (AAPL)
Allergan SHS
American Airls (AAL)
Hca Holdings (HCA)
Southwest Airlines (LUV)
Constellation Brands Cl A (STZ)
Blackstone Group Com Unit Ltd
Goldman Sachs (GS)
TransDigm Group Incorporated (TDG)
UnitedHealth (UNH)
United Rentals (URI)
Rite Aid Corporation
BioMarin Pharmaceutical (BMRN)

View all positions for Argonaut Capital Management Corp.

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Wellington Management Company
T. Rowe Price Investment Management
Geode Capital Management
Pacer Advisors
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Legal & General Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec